ITI-1284

· Intra-Cellular Therapies, Inc.

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for ITI-1284, covering 2025-01-28 to 2026-01-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease [Phase 2]

See pricing